item management s discussion and analysis of financial condition and results of operations 
results of operations versus reclassifications 
the following management s discussion and analysis of financial condition and results of operations reflect certain reclassifications made to the prior years consolidated financial statements to conform to the presentation used for the year ended december  non recurring and unusual items 
the review of results that follows excludes the impact of the non recurring and unusual items recorded in in  the company recorded a fourth quarter non cash charge of approximately   after tax to reserve the value of certain investments and notes receivable 
the decline in value of these investments was determined to be other than temporary due in part to the economic decline and tightening of the capital markets which made obtaining the additional funding that these entities require difficult 
net sales 
consolidated net sales for increased for the year with net sales increasing in all business segments on a reported basis 
excluding the impact of foreign currency  north america and europe achieved sales gains of and  while australasian sales declined 
the overall growth was primarily driven by new product introductions 
north american operations north american net sales  consisting of rehab power wheelchairs  custom manual wheelchairs  scooters and seating  standard manual wheelchairs  personal care  bed products  low air loss therapy and patient transport  continuing care beds and furniture  respiratory oxygen concentrators  aerosol therapy  sleep  homefill and associated respiratory and distributed ostomy  incontinence  diabetic  wound care and other medical supplies products grew over the prior year  adjusting for the exit of two product lines with currency translation having no material impact 
for the year  net sales of rehab products increased by driven by the continued strengthening in sales of consumer power products introduced during net sales of distributed products increased by 
however  standard and respiratory product net sales were down and  respectively  or and  respectively  adjusting for the exit of two product lines 
the standard products net sales decline is primarily due to pricing pressure from low cost imports from the far east  the company s exit from the lift out chair product line  and slow transition by customers to the new standard wheelchair product line introduced in the fourth quarter 
the decline in respiratory net sales was driven by slow purchases by national accounts and the company s exit from the liquid oxygen product line 
with reimbursement and economic uncertainty  many dealers have limited their purchases of replacement products for their rental fleets in order to preserve cash 
other products  consisting primarily of the company s canadian and aftermarket parts businesses  had a net sales decrease for the year primarily as a result of volume increases 
australasia operations the australasia products group consists of invacare australia  which imports and distributes the invacare range of products and manufactures and distributes the rollerchair range of custom power wheelchairs  dynamic controls  a new zealand manufacturer of operating components used in power wheelchairs and invacare new zealand  a distribution business 
net sales for the australasia group increased from the prior year 
excluding the impact of foreign exchange  net sales decreased for the year 
the decrease was the result of volume declines  primarily in the company s dynamic controls subsidiary 
weak global economic conditions tend to have a more significant impact on this business than the other businesses of the company 
european operations european net sales improved over the prior year  including a positive impact from foreign currency translation 
sales growth was driven by volume increases in power wheelchairs  manual wheelchairs  high action wheelchairs  patient aids and scooters 
gross profit 
consolidated gross profit as a percentage of net sales was in and in margins remained flat as the company was able to offset unfavorable product mix and pricing pressures with improved manufacturing performance 
i north american gross profit from operations as a percentage of net sales was in versus in the decrease was primarily attributable to a shift towards lower margin product lines distributed  respiratory  and consumer power products and higher freight and warranty costs 
gross profit in australasia was down by percentage points from last year 
the decline was due principally to volume declines in core markets and an increase in mix towards lower margin products  which was partially offset by manufacturing cost reductions 
gross profit in europe as a percentage of net sales improved percentage points from the prior year 
the improvement is attributable to a shift in product mix towards higher margin products  outsourcing projects that improved the european cost position and favorable currency translation 
selling  general and administrative 
consolidated selling  general and administrative expenses as a percentage of net sales were in and in the overall dollar increase was  or with currency translation increasing selling  general and administrative costs by approximately  or 
the increase is primarily in north america and the result of continued investment in marketing and branding programs being implemented to drive future growth  higher employee benefit costs  increased investment in additional headcount  additional provision for bad debts and significant increases in insurance costs largely due to general market conditions 
north american operations selling  general and administrative expenses as a percentage of net sales increased or  compared to as noted above  this increase is primarily in marketing and branding programs  additional provision for bad debt  higher employee benefit costs and significant increases in insurance costs 
australasia operations selling  general and administrative expenses decreased approximately from the prior year 
the overall dollar decline between years was  despite foreign currency increasing the expense by  the decline was due to tight expense controls 
european operations selling  general and administrative expenses increased  or from the prior year 
european selling  general and administrative expenses were negatively impacted by foreign currency translation  which increased selling  general and administrative expenses reported in dollars by  the remaining increase was due to increased systems costs and depreciation expense 
interest 
interest expense decreased to  in from  in  representing a decrease 
this decrease was attributable to the reduction in borrowings outstanding under the company s revolving credit facility and also a reduction in borrowing costs due to the low interest rate environment 
the company s debt to equity ratio decreased to 
as of december  from 
as of the end of the prior year 
interest income decreased in to  from  in the prior year  representing a decrease 
the decrease is a direct result of the minimal amount of new installment contracts that were written internally 
interest income primarily represents loan origination fees received from de lage landen inc dll 
since december  invacare customers primarily utilize the third party financing arrangement with dll  a subsidiary of rabo bank of the netherlands  to provide financing 
income taxes 
the company had an effective tax rate of in compared to in  excluding the effects of the unusual and non recurring charge recorded in the effective rate for including the unusual and non recurring charge was as a result of the valuation reserve recorded in the fourth quarter of  which was not entirely deductible for tax purposes due to limitations on capital losses 
the lower effective tax rate for is primarily due to the change in accounting for goodwill 
see income taxes and non recurring and unusual items in the notes to consolidated financial statements for further discussion of these items 
research and development 
the company continues to increase its research and development activities to maintain its competitive advantage 
while the competitive environment requires that research and development expenditures be focused on the cost reduction of products while increasing functionality and reliability  the company continues to dedicate dollars to applied research activities to ensure that new and enhanced design concepts are available to its businesses 
research and development expenditures  which are included in costs of products sold  increased to  in from  in the expenditures  as a percentage of net sales  were in and in the prior year 
i versus non recurring and unusual items 
the review of results that follows excludes the impact of the non recurring and unusual items recorded in and in  the company recorded a fourth quarter non cash charge of approximately   after tax to reserve the value of certain investments and notes receivable 
the decline in value of these investments was determined to be other than temporary due in part to the recent economic decline and tightening of the capital markets which has made obtaining the additional funding that these entities require difficult 
in  as a result of repaying euro and dkk denominated debt  the company realized a non recurring pre tax foreign currency gain of approximately  the gain was offset by charges in the fourth quarter aggregating  related primarily to closing two distribution centers and a manufacturing plant  severance costs due to staff reductions nine individuals primarily at the corporate office  and costs associated with the settlement of litigation 
in addition  during the fourth quarter of  the company also increased its bad debt reserve impacting selling  general and administrative expenses by approximately  all initiatives for which charges were reported have been completed 
net sales 
consolidated net sales for increased for the year despite a negative impact from foreign currency translation 
net sales increased in all three business segments excluding currency translation 
net sales gains were lower than last year primarily due to the slowing economy and tightening of the credit markets 
growth also was impacted by the economic shock and market uncertainty resulting from the september terrorist attacks 
however  the company believes its net sales grew faster than the overall industry  resulting in market share gains 
this net sales growth was due in part to additional marketing and branding programs and its cost effective total one stop shopping sm distribution system that is supported by the company s broad range of products and services 
north american operations north american net sales  consisting of rehab power wheelchairs  custom manual wheelchairs  seating and scooters  standard manual wheelchairs  personal care  bed products  patient transport and low air loss therapy  continuing care beds and furniture  respiratory oxygen concentrators  liquid oxygen  aerosol therapy  sleep and associated respiratory and distributed ostomy  incontinence  wound care and other medical supplies products grew over the prior year excluding the negative impact of currency translation 
all major product lines showed growth for the year 
the largest gains were recorded in continuing care  respiratory  and rehab product lines primarily due to the increased unit volumes of these products 
distributed net sales increased approximately over the prior year 
other products  consisting primarily of the company s canadian and aftermarket parts businesses  had a net sales increase for the year primarily as a result of volume increases 
australasia operations the australasia products group consists of invacare australia  which imports and distributes the invacare range of products and manufactures and distributes the rollerchair range of custom power wheelchairs  dynamic controls  a new zealand manufacturer of operating components used in power wheelchairs and invacare new zealand  a distribution business 
net sales for the australasia group increased  or from the prior year 
excluding the impact of foreign exchange  net sales increased for the year 
the increase was the result of continued expansion into the market  with volume increases in standard wheelchairs and respiratory products 
european operations european net sales improved over the prior year  excluding a negative impact from foreign currency translation 
european sales were less than expected due to reimbursement pressure in key markets throughout the year and the weak euro 
net sales growth was driven by volume increases in patient aids  homecare beds and patient transport product lines 
gross profit 
consolidated gross profit as a percentage of net sales was in and in  primarily due to product mix  pricing pressures and the decline in the euro 
continued productivity improvements and cost reduction activities partially offset these negative impacts 
north american gross profit from operations as a percentage of net sales was flat as a result of depressed margins due to pricing pressures in the supplies business which was offset by productivity improvements and cost reduction activities realized in the north american plants 
i gross profit in australasia as a percentage of net sales was down by one percent from last year 
a negative impact from foreign currency was offset by continued cost reduction activities 
gross profit in europe as a percentage of net sales declined by two percentage points from prior year 
the decline is primarily attributable to the unfavorable impact of both product and country mix  unfavorable pricing particularly in the beds and power wheelchair product lines  the negative impact of the euro and rising freight costs 
selling  general and administrative 
consolidated selling  general and administrative expenses as a percentage of net sales were approximately in and the overall dollar increase was  or with currency translation decreasing selling  general and administrative costs by approximately  or 
the minimal increase is the result of administrative cost control and the utilization of activity based budgeting aimed at allocating expense dollars to the programs that most effectively support the company s business strategy 
north american operations selling  general and administrative expenses as a percentage of net sales increased or  compared to australasia operations selling  general and administrative expenses decreased approximately from the prior year 
the overall dollar decline between years was  primarily due to the strong dollar  which reduced the expense by european operations selling  general and administrative expenses increased  or from the prior year 
european selling  general and administrative expenses were positively impacted by continued cost containment initiatives and the strong dollar  which reduced selling  general and administrative expenses reported in dollars by  interest 
interest income decreased in to  from  in the prior year  representing a decrease 
the decrease was primarily due to a decrease in installment sales volume booked in  partially offset by loan origination fees received on new business written as a result of our third party financing arrangement with dll  a subsidiary of rabo bank of the netherlands 
interest expense decreased to  in from  in  representing an decrease 
this decrease was attributable to the declining interest rate environment throughout  in conjunction with a decrease in our average borrowing outstanding under our revolver facility 
the company s debt to equity ratio decreased to 
as of december  from as of the end of the prior year 
income taxes 
the company had an effective tax rate of in compared to in  excluding the effects of the unusual and non recurring charge recorded in the effective rate for including the unusual and non recurring charge was as a result of the valuation reserve recorded in the fourth quarter of which was not entirely deductible for tax purposes due to limitations on capital losses 
see income taxes and non recurring and unusual items in the notes to consolidated financial statements for further discussion of these items 
research and development 
the company continues to increase its research and development activities to maintain its competitive advantage 
while the competitive environment requires that research and development expenditures be focused on the cost reduction of products while increasing functionality and reliability  the company continues to dedicate dollars to applied research activities to ensure that new and enhanced design concepts are available to its businesses 
research and development expenditures  which are recorded in costs of products sold  increased to  in from  in the expenditures  as a percentage of net sales  increased to from in the prior year 
inflation although the company cannot determine the precise effects of inflation  management believes that inflation does continue to have an influence on the cost of materials  salaries and benefits  utilities and outside services 
the company attempts to minimize or offset the effects through increased sales volume  capital expenditure programs designed to improve productivity  alternative sourcing of material and other cost control measures 
in and  the company was able to offset the majority of the impact of price increases from suppliers by productivity improvements and other cost reduction activities 
liquidity and capital resources the company continues to maintain an adequate liquidity position through its unused bank lines of credit see long term debt in the notes to consolidated financial statements and working capital management 
the company maintains various bank lines of credit to finance its worldwide operations 
in  the company completed a  multi currency  long term revolving credit agreement which expires on october  and a  day facility  renewed in  which expires on october  i  or such later dates as mutually agreed upon by the company and the banks 
additionally  the company maintains various other demand lines of credit totaling a us dollar equivalent of approximately  as of december  the lines of credit along with cash generated from operations have been and will continue to be used to fund the company s domestic and foreign working capital  capital expenditures and acquisition requirements 
as of december   the company had approximately  available under its various lines of credit  excluding debt covenant restrictions 
the company s borrowing arrangements contain covenants with respect to  among other items  interest coverage  net worth  dividend payments  working capital  and funded debt to capitalization  as defined in the company s bank agreements and agreement with its note holders 
the company is in compliance with all covenant requirements 
under the most restrictive covenant of the company s borrowing arrangements  the company has the capacity to borrow up to an additional  as of december  while there is general concern about the potential for rising interest rates  exposure to interest fluctuations is manageable given that a portion of the debt is at fixed rates through in addition  the ability to utilize interest rate swaps to fix a higher percentage of the company s debt coupled with free cash flow should allow invacare to absorb the expected modest rate increases in the months ahead without any material impact on our liquidity or capital resources 
as of december   the weighted average floating interest rate on us borrowings was 
capital expenditures there are no individually material capital expenditure commitments outstanding as of december  the company estimates that capital investments for will be approximately  the company believes that its balances of cash and cash equivalents  together with funds generated from operations and existing borrowing facilities  will be sufficient to meet its operating cash requirements and fund required capital expenditures for the foreseeable future 
cash flows cash flows provided by operating activities were  in  compared to  last year 
the increase is due primarily to changes in working capital accounts 
improvements in accounts receivable collections and inventory turns as well as better cash management regarding accounts payable were principally responsible for the increase in operating cash flows 
cash flows required for investing activities were comparable to  decreasing slightly by  net property and equipment activity was relatively unchanged compared to the prior year while cash received from installment sales contracts decreased significantly due to the fact that the company no longer enters into new installment contracts as a result of its third party financing arrangement with dll 
cash flows used for financing activities in were  compared to  in the increase in cash used was principally a result of the company using cash flows generated during the year to decrease its debt in by approximately  compared to  in in addition to acquisition activities  the effect of foreign currency translation results in amounts being shown in the consolidated statement of cash flows that are different from the changes reflected in the respective balance sheet captions 
dividend policy it is the company s policy to pay a nominal dividend in order for its stock to be more attractive to a broader range of investors 
the current annual dividend rate remains at 
per common share and 
per class b common share 
it is not anticipated that this will change materially as the company continues to have available significant growth opportunities through internal development and acquisitions 
for  dividends of 
per common share and 
per class b common share were declared and paid 
non recurring and unusual items in  the company recorded a fourth quarter non cash charge of approximately   after tax to reserve the value of certain investments and notes receivable 
the decline in value of these investments was determined to be other than temporary due in part to the recent economic decline and tightening of the capital markets which has made obtaining the additional funding that these entities require difficult 
in  as a result of repaying euro and dkk denominated debt  the company realized a non recurring pre tax foreign currency gain of approximately  the gain was offset by charges in the fourth quarter aggregating  related primarily to closing i two distribution centers and a manufacturing plant  severance costs due to staff reductions nine individuals primarily at the corporate office  and costs associated with the settlement of litigation 
the entire amount of these charges have been utilized in accordance with their initial designation 
in addition  during the fourth quarter of  the company also increased its bad debt reserve impacting selling  general and administrative expenses by approximately  critical accounting policies the consolidated financial statements include accounts of the company and all majority owned subsidiaries 
the preparation of financial statements in conformity with accounting principles generally accepted in the united states requires management to make estimates and assumptions in certain circumstances that affect amounts reported in the accompanying consolidated financial statements and related footnotes 
in preparing these financial statements  management has made its best estimates and judgments of certain amounts included in the financial statements  giving due consideration to materiality 
however  application of these accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties and  as a result  actual results could differ from these estimates 
revenue recognition invacare s revenues are recognized when products are shipped to unaffiliated customers 
the securities and exchange commission s staff accounting bulletin sab no 
 revenue recognition provides guidance on the application of generally accepted accounting principles to selected revenue recognition issues 
the company has concluded that its revenue recognition policy is appropriate and in accordance with generally accepted accounting principles and sab no 
allowance for uncollectible accounts receivable accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future 
substantially all of the company s receivables are due from health care  medical equipment dealers and long term care facilities located throughout the united states  australia  canada  new zealand and europe 
a significant portion of products sold to dealers  both foreign and domestic  are ultimately funded through government reimbursement programs such as medicare and medicaid 
in addition  the company has seen a significant shift in reimbursement to customers from managed care entities 
as a consequence  changes in these programs can have an adverse impact on dealer liquidity and profitability 
the estimated allowance for uncollectible amounts is based primarily on management s evaluation of the financial condition of the customer 
in addition  as a result of the third party financing arrangement with dll  management monitors the collection status of these contracts in accordance with the company s limited recourse obligations and provides amounts necessary for estimated losses in the allowance for doubtful accounts 
inventories and related allowance for obsolete and excess inventory inventories are valued at the lower of cost or market value and have been reduced by an allowance for excess and obsolete inventories 
the estimated allowance is based on management s review of inventories on hand compared to estimated future usage and sales 
goodwill  intangible and other long lived assets property  equipment  intangibles and certain other long lived assets are amortized over their useful lives 
useful lives are based on management s estimates of the period that the assets will generate revenue 
as a result of the adoption of sfas no 
 goodwill and other intangible assets in  goodwill and intangible assets deemed to have indefinite lives are subject to annual impairment tests in accordance with the statement 
furthermore  goodwill and other long lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable 
the company completed the required initial analysis of goodwill as of january  as well the annual impairment test in the fourth quarter of the results of these analyses indicated no impairment of goodwill 
product liability the company s captive insurance company  invatection insurance co  currently has a policy year that runs from september to august and insures individual losses up to million and annual aggregate policy losses of million of the company s domestic product liability exposure 
the company also has additional layers of coverage insuring million in annual aggregate losses arising from individual claims that exceed the captive insurance company policy limits 
invatection records product liability reserves for both known claims and incurred but not reported claims based upon independent actuarial valuations 
there can be no assurance that invacare s current insurance levels will continue to be adequate or available at an affordable rate 
warranty generally  the company s products are covered by warranties against defects in material and workmanship for periods up to six years from the date of sale to the customer 
certain components carry a lifetime warranty 
a provision for estimated warranty cost is recorded at the time of sale based upon actual experience 
the company continuously assesses the adequacy of its product warranty accrual and makes adjustments as needed 
see current liabilities in the notes to the consolidated financial statements for a reconciliation of the changes in the warranty accrual 
i accounting for stock based compensation the company accounts for options under its stock based compensation plans using the intrinsic value method proscribed in apb opinion no 
 accounting for stock issued to employees  and related interpretations 
the majority of the options awarded have been granted at exercise prices equal to the market value of the underlying stock on the date of grant  thus  no compensation cost has been reflected in the consolidated statement of earnings for these options 
in addition  restricted stock awards have been granted without cost to the recipients and are being expensed on a straight line basis over the vesting periods 
if the company had applied the fair value recognition provisions of sfas no 
accounting for stock based compensation for all stock options granted  net earnings per share assuming dilution would have been reduced by 
in  
in and 
in in december  the financial accounting standards board fasb issued statement of financial accounting standard sfas no 
 accounting for stock based compensation transition and disclosure 
this statement provides guidance for those companies wishing to voluntarily change to the fair value based method of accounting for stock based compensation 
the statement also amends the disclosure requirements of sfas no 
while invacare continues to utilize the disclosure only provisions of sfas no 
 the company has modified its disclosures to comply with the new statement 
see the company s accounting policies and shareholders equity transactions in the notes to the consolidated financial statements 
recently issued accounting pronouncements in june  the fasb issued sfas no 
 accounting for the costs associated with exit or disposal activities  which addresses financial accounting and reporting for costs associated with exit or disposal activities 
the provisions of this statement  which is effective for exit or disposal activities that are initiated after december   are not expected to have a material impact on the company s financial position  results of operations or cash flows 
item a 
quantitative and qualitative disclosure about market risk the company is exposed to market risk through various financial instruments  including fixed rate and floating rate debt instruments 
the company uses interest swap agreements to mitigate its exposure to interest rate fluctuations 
based on december  debt levels  a change in interest rates would impact interest expense by approximately  additionally  the company operates internationally and as a result is exposed to foreign currency fluctuations 
specifically  the exposure includes intercompany loans  and third party sales or payments 
in an attempt to reduce this exposure  foreign currency forward contracts are utilized 
the company does not believe that any potential loss related to these financial instruments would have a material adverse effect on the company s financial condition or results of operations 
private securities litigation reform act the statements contained in this form k constitute forward looking statements within the meaning of the safe harbor provisions of the private securities litigation reform act of terms such as will  should  achieve  increase  plan  can  expect  pursue  benefit  continue  exceed  improve  believe  estimate  anticipate  build  strengthen  new  lower  drive  seek  hope  and create  as well as similar comments  are forward looking in nature 
actual results and events may differ significantly from those expressed or anticipated as a result of risks and uncertainties which include  but are not limited to  the following pricing pressures  increasing raw material costs  the consolidations of health care customers and competitors  government reimbursement issues including those that affect the viability of customer  the ability to design  manufacture and distribute new products with higher functionality and lower costs and the ability to accelerate market acceptance of and transition to new products  the effect of offering customers competitive financing terms  invacare s ability to effectively identify  acquire and integrate acquisition candidates  the difficulties in managing and operating businesses in many different foreign jurisdictions  the timely and efficient completion of facility consolidations  the vagaries of any litigation or regulatory investigations that the company may be or become involved in at any time  the difficulties in acquiring and maintaining a proprietary intellectual property ownership position  the overall economic  market and industry growth conditions  foreign currency and interest rate risk  invacare s ability to improve financing terms and reduce working capital  as well as the risks described from time to time in invacare s reports as filed with the securities and exchange commission 
the company undertakes no obligation to update any of the forward looking or other information contained herein 

